Gurská Soňa Ph.D.

Journals

SUAREZ, A., K. CHAVEZ, J. GARMENDIA, C. DE SANTCTIS, S. GURSKÁ, P. DŽUBÁK, M. HAJDÚCH, J. DE SANCTIS
New Derivatives of Caracasine Acid with Anti-Leukemic Activity and Limited Effectiveness in Spheroid Cultures. Pharmaceuticals . 2025, 18(7), 1043, ISSN: 1424-8247, PMID: 40732330,  PDF.
JURÁŠEK, M., E. DRABEROVA, J. ŘEHULKA, S. GURSKÁ, A. IVANOVA (NIKONENKO), P. POLISHCHUK, K. JEČMEŇOVÁ, J. FAHNRICH, A. MARESOVA, J. TAUCHEN, A. REYES ROMERO, A. DÖMLING, M. HAJDÚCH, P. DRAŠAR, P. DRABER, P. DŽUBÁK
Colchicine-BODIPY Probes: Evidence for the Involvement of Intracellular Membranes in the Targeting of Colchicine to Tubulin. ACS pharmacology & translational science. 2025, 8(7), 1965-1985, ISSN: 2575-9108, PMID: 40672674,  PDF.
FRYDRYCH, I., B. CHROMA, L. SLAVIKOVA, J. POKORNÝ, N. JAKUBCOVÁ, S. LUDHA, S. GURSKÁ, J. ŘEHULKA, B. LIŠKOVÁ, P. DŽUBÁK, M. HAJDÚCH, M. URBAN
Novel C-2 Aromatic Heterocycle-Substituted Triterpenoids Inhibit Hedgehog Signaling in GLI1 Overexpression Cancer Cells. ACS Omega. 2025, 10(10), 10617-10632, ISSN: 2470-1343, PMID: 40124057,  PDF.

Books & book chapters

GURSKÁ, S.
Analysis of cytotoxicity by tetrazolium salt reduction test , 1.vyd., Olomouc, Palacky University, 2021, 10, 67-72, Dedication: LO1304, ISBN: 978-80-244-6049-9,

Intellectual property

RNA ISOLATION KIT (Džubák)

Utility Model: CZ 35067. Granted: 18.5.2021. Ownership: Palacký University Olomouc. Inventors: DŽUBÁK Petr, HAJDÚCH Marián, GURSKÁ Soňa, KOUDELÁKOVÁ Vladimíra, JAWOREK Hana.

Status: Available

Master mentorship

Synek Vojtěch

Development of the assay for measurement of the CA activity and its implementation into HTS

Stav: Absolvoval od 2018 do 2020.
Dostálová Kristýna

Cell-based assays for high-throughput screening in drug discovery

Stav: Absolvoval od 2014 do 2016.
Voltemarová Tereza

Cytotoxicity profiling of new potentially bioactive compounds using high throughput screening (HTS)

Stav: Absolvoval od 2019 do 2021.

Bachelor mentorship

Jamborová Petra

Establishment and characterization of anticancer drug resistant leukemic cell lines

Stav: Absolvoval od 2023 do 2024.
Synek Vojtěch

Cytotoxicity tests for high-throughput drug discovery

Stav: Absolvoval od 2014 do 2018.
Zabáková Dominika

Analysis of the cytotoxic effects of new chemical substances in HTS conditions

Stav: Absolvoval od 2021 do 2021.